Skip to content

Study to estimate the minimum clinically different difference in visual analogue scale scores for skin swelling, skin pain and abdominal pain in subjects with hereditary angio-edema

Study to estimate the minimum clinically different difference in visual analogue scale scores for skin swelling, skin pain and abdominal pain in subjects with hereditary angio-edema - VAS score angio-edema attack

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30040
Enrollment
20
Registered
2006-08-30
Start date
2006-09-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditairy angio-edema

Interventions

None listed

Sponsors

Jerini AG
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with documented type I or type II hereditary angio-edema (confirmed by medical history and C1-INH deficiency) History of angio-edema attacks involving skin and/or abdomen Male or Female Age > 18 yrs Signed written informed consent

Exclusion criteria

Exclusion criteria: Diagnosis of angio-edema other than HAE, e.g. acquired angio-edema Patients participating in other trials Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study Patients unlikely to comply with protocol, e.g. uncooperative attitude, inability to return for follow-up, and unlikely to complete the study for any reason

Design outcomes

Primary

MeasureTime frame
Descriptive research based on which the "minimally clinically significant difference" in symptomscore can be assessed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)